Reading the bill…
Our AI is translating this into plain English. Usually takes 10–15 seconds.
Coverage of the 119th Congress
Reading the bill…
Our AI is translating this into plain English. Usually takes 10–15 seconds.
Current Status
Referred to the House Committee on Energy and Commerce.
Sponsor
Andy Biggs
Introduced
March 21, 2026
How far this bill has traveled through Congress
Introduced
Committee
Passed Chamber
Passed Both
President
Enacted
Introduced
Bill filed in chamber
Committee
Reviewed & reported
Passed Chamber
House or Senate vote
Passed Both
House & Senate agree
President
Sent to White House
Enacted
Signed into law
Latest Action
Referred to the House Committee on Energy and Commerce.
This bill would exempt non-invasive diagnostic devices from federal regulation. It defines what a non-invasive device is and allows them to be sold without needing FDA approval. This could speed up the development of new medical technologies, such as portable blood glucose monitors and skin-conductance sensors.
This bill could help medical innovators develop new technologies faster, which could improve the quality of care for patients and advance the field of medicine.
No position data available yet
Source: cosponsors
No position data available yet
Source: cosponsors
Cosponsor data and vote records sourced from Congress.gov. Reflects formal legislative actions only — not editorial opinion.
No representative stances found yet. Check back after the next scraping cycle.